Mayer Eldon C. Iii - Net Worth and Insider Trading
Mayer Eldon C. Iii Net Worth
The estimated net worth of Mayer Eldon C. Iii is at least $241,490 dollars as of 2024-04-27. Mayer Eldon C. Iii is the EVP & Chief Commercial Officer of Rigel Pharmaceuticals Inc and owns about 215,000 shares of Rigel Pharmaceuticals Inc (RIGL) stock worth over $236,500. Mayer Eldon C. Iii is also the Ex VP & Chief Commerc. Officer of Eiger BioPharmaceuticals Inc and owns about 1,869 shares of Eiger BioPharmaceuticals Inc (EIGRQ) stock worth over $4,990. Details can be seen in Mayer Eldon C. Iii's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Mayer Eldon C. Iii has not made any transactions after 2023-03-17 and currently still holds the listed stock(s).
Transaction Summary of Mayer Eldon C. Iii
Mayer Eldon C. Iii Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Mayer Eldon C. Iii owns 2 companies in total, including Eiger BioPharmaceuticals Inc (EIGRQ) , and Rigel Pharmaceuticals Inc (RIGL) .
Click here to see the complete history of Mayer Eldon C. Iii’s form 4 insider trades.
Insider Ownership Summary of Mayer Eldon C. Iii
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| EIGRQ | Eiger BioPharmaceuticals Inc | 2023-03-17 | Ex VP & Chief Commerc. Officer |
| RIGL | Rigel Pharmaceuticals Inc | 2018-09-11 | EVP & Chief Commercial Officer |
Mayer Eldon C. Iii Latest Holdings Summary
Mayer Eldon C. Iii currently owns a total of 2 stocks. Among these stocks, Mayer Eldon C. Iii owns 215,000 shares of Rigel Pharmaceuticals Inc (RIGL) as of September 11, 2018, with a value of $236,500 and a weighting of 97.93%. Mayer Eldon C. Iii also owns 1,869 shares of Eiger BioPharmaceuticals Inc (EIGRQ) as of March 17, 2023, with a value of $4,990 and a weighting of 2.07%.
Latest Holdings of Mayer Eldon C. Iii
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| RIGL | Rigel Pharmaceuticals Inc | 2018-09-11 | 215,000 | 1.10 | 236,500 |
| EIGRQ | Eiger BioPharmaceuticals Inc | 2023-03-17 | 1,869 | 2.67 | 4,990 |
Holding Weightings of Mayer Eldon C. Iii
Mayer Eldon C. Iii Form 4 Trading Tracker
According to the SEC Form 4 filings, Mayer Eldon C. Iii has made a total of 0 transactions in Rigel Pharmaceuticals Inc (RIGL) over the past 5 years. The most-recent trade in Rigel Pharmaceuticals Inc is the acquisition of 100,000 shares on September 11, 2018, which cost Mayer Eldon C. Iii around $326,000.
According to the SEC Form 4 filings, Mayer Eldon C. Iii has made a total of 5 transactions in Eiger BioPharmaceuticals Inc (EIGRQ) over the past 5 years, including 1 buys and 4 sells. The most-recent trade in Eiger BioPharmaceuticals Inc is the sale of 146 shares on March 17, 2023, which brought Mayer Eldon C. Iii around $4,703.
Insider Trading History of Mayer Eldon C. Iii
- 1
Mayer Eldon C. Iii Trading Performance
GuruFocus tracks the stock performance after each of Mayer Eldon C. Iii's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Mayer Eldon C. Iii is -5.64%. GuruFocus also compares Mayer Eldon C. Iii's trading performance to market benchmark return within the same time period. The performance of stocks bought by Mayer Eldon C. Iii within 3 months outperforms 2 times out of 4 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Mayer Eldon C. Iii's insider trading performs compared to the benchmark.
Performance of Mayer Eldon C. Iii
Average Return
-17.69%
Outperforming Transactions
25%
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | -1.36 | -5.64 | -13.61 | -17.69 | -17.61 | -12.79 |
| Relative Return to S&P 500(%) | 2.22 | 1.38 | -11.95 | -26.41 | -29.5 | -27.26 |
Mayer Eldon C. Iii Ownership Network
Ownership Network List of Mayer Eldon C. Iii
Ownership Network Relation of Mayer Eldon C. Iii
Mayer Eldon C. Iii Owned Company Details
What does Eiger BioPharmaceuticals Inc do?
Who are the key executives at Eiger BioPharmaceuticals Inc?
Mayer Eldon C. Iii is the Ex VP & Chief Commerc. Officer of Eiger BioPharmaceuticals Inc. Other key executives at Eiger BioPharmaceuticals Inc include 10 percent owner Richard A Kayne , 10 percent owner Leen Kawas , and Chief Business Officer Ingrid Choong .
Eiger BioPharmaceuticals Inc (EIGRQ) Insider Trades Summary
Over the past 18 months, Mayer Eldon C. Iii made 1 insider transaction in Eiger BioPharmaceuticals Inc (EIGRQ) with a net sale of 4,395. Other recent insider transactions involving Eiger BioPharmaceuticals Inc (EIGRQ) include a net purchase of 27,500 shares made by Thomas John Dietz , a net purchase of 278,239 shares made by Richard A Kayne , and a net purchase of 100,000 shares made by Jeffrey S Glenn .
In summary, during the past 3 months, insiders sold 0 shares of Eiger BioPharmaceuticals Inc (EIGRQ) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 896 shares of Eiger BioPharmaceuticals Inc (EIGRQ) were sold and 15,086 shares were bought by its insiders, resulting in a net purchase of 14,189 shares.
Eiger BioPharmaceuticals Inc (EIGRQ)'s detailed insider trading history can be found in Insider Trading Tracker table.
Eiger BioPharmaceuticals Inc Insider Transactions
Mayer Eldon C. Iii Mailing Address
Above is the net worth, insider trading, and ownership report for Mayer Eldon C. Iii. You might contact Mayer Eldon C. Iii via mailing address: Rigel Pharmaceuticals, Inc., 1180 Veterans Blvd., South San Francisco Ca 94080.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
